This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: j.jacc.2007.04.069v1 50/8/808    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (16) Citing Articles via Google Scholar Google Scholar Articles by Liu, X. Articles by Janssens, S. Search for Related Content PubMed PubMed Citation Articles by Liu, X. Articles by Janssens, S.

PRECLINICAL STUDY

Nitric Oxide Inhalation Improves Microvascular Flow and Decreases Infarction Size After Myocardial Ischemia and Reperfusion

Xiaoshun Liu, MD, PhD^_*, Yanming Huang, MD, PhD^_*, Peter Pokreisz, PhD, Pieter Vermeersch, MD, Glenn Marsboom, MSc, Marc Swinnen^_*, Eric Verbeken, MD, PhD, Jose Santos, MD^_*, Marijke Pellens, Hilde Gillijns, Frans Van de Werf, MD, PhD^_*, Kenneth D. Bloch, MD^,2 and Stefan Janssens, MD, PhD^_*,,1,2,_*

^_* Department of Cardiology, University of Leuven, Leuven, Belgium
Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute of Biotechnology, University of Leuven, Leuven, Belgium
Department of Pathology, University of Leuven, Leuven, Belgium
Cardiovascular Research Center, Department of Medicine, and Department of Anesthesia and Critical Care, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Manuscript received October 3, 2006; revised manuscript received April 2, 2007, accepted April 10, 2007.

^_* Reprint requests and correspondence: Dr. Stefan Janssens, Department of Cardiology and Center for Transgene Technology and Gene Therapy, University of Leuven, Belgium. (Email: stefan.janssens{at}uz.kuleuven.ac.be).

Objectives: The purpose of this study was to test if nitric oxide (NO) could improve microvascular perfusion and decrease tissue injury in a porcine model of myocardial ischemia and reperfusion (I/R).

Background: Inhaled NO is a selective pulmonary vasodilator with biologic effects in remote vascular beds.

Methods: In 37 pigs, the midportion of the left anterior descending coronary artery was occluded for 50 min followed by 4 h of reperfusion. Pigs were treated with a saline infusion (control; n = 14), intravenous nitroglycerin (IV-NTG) at 2 µg/kg/min (n = 11), or inhaled nitric oxide (iNO) at 80 parts per million (n = 12) beginning 10 min before balloon deflation and continuing throughout reperfusion.

Results: Total myocardial oxidized NO species in the infarct core was greater in the iNO pigs than in the control or IV-NTG pigs (0.60 ± 0.05 nmol/mg tissue vs. 0.40 ± 0.03 nmol/mg tissue and 0.40 ± 0.02 nmol/mg tissue, respectively; p < 0.01 for both). Infarct size, expressed as percentage of left ventricle area at risk (AAR), was smaller in the iNO pigs than in the control or IV-NTG pigs (31 ± 6% AAR vs. 58 ± 7% AAR and 46 ± 7% AAR, respectively; p < 0.05 for both) and was associated with less creatine phosphokinase-MB release. Inhaled NO improved endocardial and epicardial blood flow in the infarct zone, as measured using colored microspheres (p < 0.001 vs. control and IV-NTG). Moreover, NO inhalation reduced leukocyte infiltration, as reflected by decreased cardiac myeloperoxidase activity (0.8 ± 0.2 U/mg tissue vs. 2.3 ± 0.8 U/mg tissue in control and 1.4 ± 0.4 U/mg tissue in IV-NTG; p < 0.05 for both) and decreased cardiomyocyte apoptosis in the infarct border zone.

Conclusions: Inhalation of NO just before and during coronary reperfusion significantly improves microvascular perfusion, reduces infarct size, and may offer an attractive and novel treatment of myocardial infarction.

Abbreviations and Acronyms   AAR = area at risk   iNO = inhaled nitric oxide   LV = left ventricle/ventricular   MPO = myeloperoxidase   MVO = microvascular obstruction   NO = nitric oxide   NOx = oxidized nitric oxide species   NTG = nitroglycerin

This article has been cited by other articles:

				S. Minamishima, K. Kida, K. Tokuda, H. Wang, P. Y. Sips, S. Kosugi, J. B. Mandeville, E. S. Buys, P. Brouckaert, P. K. Liu, et al. Inhaled Nitric Oxide Improves Outcomes After Successful Cardiopulmonary Resuscitation in Mice Circulation, October 11, 2011; 124(15): 1645 - 1653. [Abstract] [Full Text] [PDF]

				Y. Zhang, S. P. Janssens, K. Wingler, H. H. H. W. Schmidt, and A. L. Moens Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy Am J Physiol Heart Circ Physiol, September 1, 2011; 301(3): H634 - H646. [Abstract] [Full Text] [PDF]

				Q. Yu, F. Gao, and X. L. Ma Insulin says NO to cardiovascular disease Cardiovasc Res, February 15, 2011; 89(3): 516 - 524. [Abstract] [Full Text] [PDF]

				S. J. McSweeney, P. W. F. Hadoke, A. M. Kozak, G. R. Small, H. Khaled, B. R. Walker, and G. A. Gray Improved heart function follows enhanced inflammatory cell recruitment and angiogenesis in 11{beta}HSD1-deficient mice post-MI Cardiovasc Res, October 1, 2010; 88(1): 159 - 167. [Abstract] [Full Text] [PDF]

				B. I. Jugdutt, A. Jelani, A. Palaniyappan, H. Idikio, R. E. Uweira, V. Menon, and C. E. Jugdutt Aging-Related Early Changes in Markers of Ventricular and Matrix Remodeling After Reperfused ST-Segment Elevation Myocardial Infarction in the Canine Model: Effect of Early Therapy With an Angiotensin II Type 1 Receptor Blocker Circulation, July 27, 2010; 122(4): 341 - 351. [Abstract] [Full Text] [PDF]

				F. M. Gonzalez, S. Shiva, P. S. Vincent, L. A. Ringwood, L.-Y. Hsu, Y. Y. Hon, A. H. Aletras, R. O. Cannon III, M. T. Gladwin, and A. E. Arai Nitrite Anion Provides Potent Cytoprotective and Antiapoptotic Effects as Adjunctive Therapy to Reperfusion for Acute Myocardial Infarction Circulation, June 10, 2008; 117(23): 2986 - 2994. [Abstract] [Full Text] [PDF]